Tag archive for ‘CNS’
Gil Tanenbaum On Monday, November 17th, 2014

NeuroDerm’s IPO Comes Up Short

– Israel’s NeuroDerm, which has developed a transdermal drug delivery system for the treatment of Parkinson’s disease, held a less than stellar IPO on the NASDAQ, selling 4.5 million shares More...

Gil Tanenbaum On Monday, November 3rd, 2014

Pharmaceutical NeuroDerm Prepares for NASDAQ IPO

NeuroDerm Ltd., an Israeli clinical stage pharmaceutical company which develops drugs for central nervous system (CNS) diseases, announced the launch of its initial public offering of 4.5 million ordinary More...

Gil Tanenbaum On Thursday, August 28th, 2014

Neuroderm Raises $16 Million for Parkinson’s Cure

Israel’s NeuroDerm Ltd., announced that it raised $16 million to further the clinical and regulatory development of its Levodopa products, combating Parkinson’s disease. ND0612L, NeuroDerm’s More...

Wordpress site Developed by Fixing WordPress Problems